Kinnevik Investment

Upgrading our NAV; Babylon goes the SPAC route

03/06/21 -"We updated our estimated DCF following the announcement of Babylon Health's definitive merger agreement with the SPAC Alkuri Global, through which the London-based digital healthcare company will ..."

PDF page sample
Pages
63
Language
English
Published on
03/06/21
Download
You may also be interested by these reports :
13/11/25
Sonae released very strong Q3 25 results, driven by a strong performance across its retail business, which is becoming more than just a defensive ...
12/11/25
A pending Brazilian presidential decree, featuring a cap on meal voucher commission and measures to increase competition, has raised market concerns ...
11/11/25
Adyen hosted its 2025 Investor Day on 11 November. This “Investor Day 2025” provided fresh long-term guidance that reassured investors amid a ...
07/11/25
Our EPS for 2025 was affected by lower operating results from direct private assets, leading us to cut our revenue forecasts and increase costs from ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO